Nasdaq moves to delist GlucoTrack over minimum bid price violation
GCTK•Nasdaq notified GlucoTrack on October 28, 2026, that its securities would be delisted, with trading in its common stock set to be suspended at the open on October 30. The company expects the stock to be quoted on OTC Markets and plans to apply for the OTCID Market.
1. Nasdaq delisting notice
Nasdaq notified GlucoTrack on October 28 that its securities would be delisted for failing to meet minimum bid price requirements. The closing bid price of $0.87 on October 14 breached an exception under Nasdaq Listing Rule 5550(a)(2), which required a closing bid of at least $1 each trading day through November 9. Trading in the common stock will be suspended at the open on October 30. GlucoTrack expects its stock to be quoted on OTC Markets and plans to apply for the OTCID Market.
